Seroprevalence of Hepatitis B and C Infections among Healthy Volunteer Blood Donors in the Central California Valley
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: The Central California Valley has a diverse population with significant proportions of Hispanics and Asians. This cross-sectional study was conducted to evaluate the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in healthy blood donors in the Valley. Methods: A total of 217,738 voluntary blood donors were identified between 2006 and 2010 (36,795 first-time donors; 180,943 repeat donors). Results: Among the first-time donors, the HBV and HCV prevalence was 0.28% and 0.52%, respectively. Higher HBV prevalence seen in Asians (3%) followed by Caucasians (0.05%), African Americans (0.15%), and Hispanics (0.05%). Hmong had a HBV prevalence of 7.63% with a peak prevalence of 8.76% among the 16- to 35-year-old age group. Highest HCV prevalence in Native Americans (2.8) followed by Caucasians (0.59%), Hispanics (0.45%), African Americans (0.38%), and Asians (0.2%). Conclusions: Ethnic disparities persist with regard to the prevalence of HBV and HCV in the Central California Valley. The reported prevalence may be an underestimate because our study enrolled healthy volunteer blood donors only. The development of aggressive public health measures to evaluate the true prevalence of HBV and HCV and to identify those in need of HBV and HCV prevention measures and therapy is critically important.
Abstract
Background/Aims: The Central California Valley has a diverse population with significant proportions of Hispanics and Asians. This cross-sectional study was conducted to evaluate the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in healthy blood donors in the Valley. Methods: A total of 217,738 voluntary blood donors were identified between 2006 and 2010 (36,795 first-time donors; 180,943 repeat donors). Results: Among the first-time donors, the HBV and HCV prevalence was 0.28% and 0.52%, respectively. Higher HBV prevalence seen in Asians (3%) followed by Caucasians (0.05%), African Americans (0.15%), and Hispanics (0.05%). Hmong had a HBV prevalence of 7.63% with a peak prevalence of 8.76% among the 16- to 35-year-old age group. Highest HCV prevalence in Native Americans (2.8) followed by Caucasians (0.59%), Hispanics (0.45%), African Americans (0.38%), and Asians (0.2%). Conclusions: Ethnic disparities persist with regard to the prevalence of HBV and HCV in the Central California Valley. The reported prevalence may be an underestimate because our study enrolled healthy volunteer blood donors only. The development of aggressive public health measures to evaluate the true prevalence of HBV and HCV and to identify those in need of HBV and HCV prevention measures and therapy is critically important.
참고문헌 (42)
- Ott JJ, "Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity", Vaccine, 30, pp.2212~2219 (2012)
- Nelson PK, "Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews", Lancet, 378, pp.571~583 (2011)
- El-Serag HB, "Hepatocellular carcinoma", N Engl J Med, 365, pp.1118~1127 (2011)
- Ly KN, "The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007", Ann Intern Med, 156, pp.271~278 (2012)
- Custer B, "Global epidemiology of hepatitis B virus", J Clin Gastroenterol, 38(10 Suppl 3), pp.S158~S168 (2004)
- Centers for Disease Control and Prevention (CDC), "Screening for chronic hepatitis B among Asian", Pacific Islander populations: New York City, 2005, 2006, pp.55, 505~509
- Rawls RA, "Viral hepatitis in minority America", J Clin Gastroenterol, 39, pp.144~151 (2005)
- Xu J, "Division of Vital Statistics. Deaths: final data for 2007", Natl Vital Stat Rep, 58, pp.1~136 (2010)
- Kim WR, "Epidemiology of hepatitis B in the United States", Hepatology, 49(5 Suppl), pp.S28~S34 (2009)
- Wasley A, "The prevalence of hepatitis B virus infection in the United States in the era of vaccination", J Infect Dis, 202, pp.192~201 (2010)
- Armstrong GL, "The prevalence of hepatitis C virus infection in the United States, 1999 through 2002", Ann Intern Med, 144, pp.705~714 (2006)
- Rustgi VK, "The epidemiology of hepatitis C infection in the United States", J Gastroenterol, 42, pp.513~521 (2007)
- Sy T, "Epidemiology of hepatitis C virus (HCV) infection", Int J Med Sci, 3, pp.41~46 (2006)
- Bonacini M, "Chronic hepatitis C in ethnic minority patients evaluated in Los Angeles County", Am J Gastroenterol, 96, pp.2438~2441 (2001)
- Blessman DJ, "Chronic hepatitis C in the Hispanic", Latino population living in the United States: a literature review, 2008, pp.31, 17~25
- Younossi ZM, "Hepatitis C virus infection, age, and Hispanic ethnicity increase mortality from liver cancer in the United States", Clin Gastroenterol Hepatol, 8, pp.718~723 (2010)
- Scott JD, "Chronic liver disease in Aboriginal North Americans", World J Gastroenterol, 14, pp.4607~4615 (2008)
- Flores YN, "Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999-2004", Am J Gastroenterol, 103, pp.2231~2238 (2008)
- Denniston MM, "Awareness of infection, knowledge of hepatitis C, and medical follow-up among individuals testing positive for hepatitis C: National Health and Nutrition Examination Survey 2001-2008", Hepatology, 55, pp.1652~1661 (2012)
- Mitchell AE, "Institute of Medicine recommendations for the prevention and control of hepatitis B and C", Hepatology, 51, pp.729~733 (2010)
- "American community survey" (2010)[URL]
- Sheikh MY, "Prevalence of hepatitis B virus (HBV) infection among Hmong immigrants in the San Joaquin Valley", J Community Health, 36, pp.42~46 (2011)
- Rodriguez-Torres M, "Latinos and chronic hepatitis C: a singular population", Clin Gastroenterol Hepatol, 6, pp.484~490 (2008)
- Rodriguez-Torres M, "Peginterferon alfa-2a and ribavirin in Latino and non-Latino whites with hepatitis C", N Engl J Med, 360, pp.257~267 (2009)
- Fridey JL, "A question of clarity: redesigning the American Association of Blood Banks blood donor history questionnaire: a chronology and model for donor screening", Transfus Med Rev, 21, pp.181~204 (2007)
- Glynn SA, "Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS)", JAMA, 284, pp.229~235 (2000)
- Busch MP, "Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV-1 antibody screening. The Transfusion Safety Study Group", Transfusion, 31, pp.4~11 (1991)
- Zuck TF, "Transfusion-transmitted AIDS reassessed", N Engl J Med, 318, pp.511~551 (1988)
- "NHANES 2001-2002 public data general release file documentation" (2004)[URL]
- McQuillan GM, "Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994", Am J Public Health, 89, pp.14~18 (1999)
- Bastiaans MJ, "Hepatitis-associated markers in the American Red Cross volunteer blood donor population. IV. A comparison of HBV-associated serologic markers in HBsAg-positive first-time and repeat blood donors", Vox Sang, 42, pp.203~210 (1982)
- Daniels D, "Centers for Disease Control and Prevention (CDC). Surveillance for acute viral hepatitis: United States, 2007", MMWR Surveill Summ, 58, pp.1~27 (2009)
- Coleman PJ, "Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys", J Infect Dis, 178, pp.954~959 (1998)
- Murphy EL, "Demographic determinants of hepatitis C virus seroprevalence among blood donors", JAMA, 275, pp.995~1000 (1996)
- Zou S, "Patterns of age- and sex-specific prevalence of major blood-borne infections in United States blood donors, 1995 to 2002: American Red Cross blood donor study", Transfusion, 44, pp.1640~1647 (2004)
- Murphy EL, "Hepatitis C virus prevalence and clearance among US blood donors, 2006-2007: associations with birth cohort, multiple pregnancies, and body mass index", J Infect Dis, 202, pp.576~584 (2010)
- Wiley TE, "Hepatitis C infection in African Americans: its natural history and histological progression", Am J Gastroenterol, 97, pp.700~706 (2002)
- Muir AJ, "Atlantic Coast Hepatitis Treatment Group. Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and non-Hispanic whites", N Engl J Med, 350, pp.2265~2271 (2004)
- Neumeister AS, "Hepatitis-C prevalence in an urban native-American clinic: a prospective screening study", J Natl Med Assoc, 99, pp.389~392 (2007)
- Singh GK, "Social epidemiology of chronic liver disease and cirrhosis mortality in the United States, 1935-1997: trends and differentials by ethnicity, socioeconomic status, and alcohol consumption", Hum Biol, 72, pp.801~820 (2000)
- McMahon BJ, "Epidemiology and risk factors for hepatitis C in Alaska natives", Hepatology, 39, pp.325~332 (2004)
- Solomon L, "Prevalence of HIV, syphilis, hepatitis B, and hepatitis C among entrants to Maryland correctional facilities", J Urban Health, 81, pp.25~37 (2004)
